Mona L Martin
Biographic Data
| ID | 7692918 |
|---|---|
| NAME | Mona L Martin |
| GIVEN NAMES | Mona L |
| FAMILY NAME | Martin |
| SIGNATURE | MARTIN M L |
| AFFILIATIONS | Williams & Associates |
| ORCID | 0000-0001-6899-2139 |
| VERIFIED | Yes |
| TOTAL WORKS | 10 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 10 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1999 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
How patients being treated for non-small cell lung cancer value treatment benefit despite side effects
In these two qualitative sub-studies, patients with advanced NSCLC valued the benefits of their treatment regardless of side effects that they experienced. Patients weighed their options against the seriousness of their disease and expressed their willingness to tolerate their side effects in return for receiving continued treatment benefits
Willingness to report treatment-related symptoms of immunotherapy among patients with non-small cell lung cancer
Patients have a range of reasons for not reporting their treatment-related symptoms when undergoing immunotherapy for NSCLC. Reasons are more strongly related to determination of the severity versus manageability of patients' experiences of symptoms than they are to the fear of having treatment discontinued
Content validity of the ASQoL for use in a non-radiographic axial spondyloarthritis population
Our results represent an important first step in confirming the relevance of the concepts in the ASQoL to patients with nr-axSpA, supporting quantitative assessment of ASQoL validity in this population
Qualitative development of the ‘Questionnaire on Pain caused by Spasticity (QPS),’ a pediatric patient‐reported outcome for spasticity‐related pain in cerebral palsy
The QPS is a novel instrument for the assessment of spasticity-related pain in children/adolescents with CP that was developed with direct patient input. Its modules allow the use of this instrument in children/adolescents with varied levels of impairment and communication skills
Equivalence and measurement properties of an electronic version of the Psoriasis Symptom Inventory
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation
Content validation of two SF-36 subscales for use in type 2 diabetes and non-dialysis chronic kidney disease-related anemia
Quality of Life of Women with Urinary Incontinence
Quality of life and parkinson's disease
No prominent works on this page.
Quality of life and parkinson's disease
Quality of Life of Women with Urinary Incontinence
Content validation of two SF-36 subscales for use in type 2 diabetes and non-dialysis chronic kidney disease-related anemia
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation
Qualitative development of the ‘Questionnaire on Pain caused by Spasticity (QPS),’ a pediatric patient‐reported outcome for spasticity‐related pain in cerebral palsy
The QPS is a novel instrument for the assessment of spasticity-related pain in children/adolescents with CP that was developed with direct patient input. Its modules allow the use of this instrument in children/adolescents with varied levels of impairment and communication skills
Equivalence and measurement properties of an electronic version of the Psoriasis Symptom Inventory
Content validity of the ASQoL for use in a non-radiographic axial spondyloarthritis population
Our results represent an important first step in confirming the relevance of the concepts in the ASQoL to patients with nr-axSpA, supporting quantitative assessment of ASQoL validity in this population
How patients being treated for non-small cell lung cancer value treatment benefit despite side effects
In these two qualitative sub-studies, patients with advanced NSCLC valued the benefits of their treatment regardless of side effects that they experienced. Patients weighed their options against the seriousness of their disease and expressed their willingness to tolerate their side effects in return for receiving continued treatment benefits
Willingness to report treatment-related symptoms of immunotherapy among patients with non-small cell lung cancer
Patients have a range of reasons for not reporting their treatment-related symptoms when undergoing immunotherapy for NSCLC. Reasons are more strongly related to determination of the severity versus manageability of patients' experiences of symptoms than they are to the fear of having treatment discontinued
Medicine (10 works) · Physical therapy (6 works) · Psychology (5 works) · Internal Medicine (4 works) · Population (4 works) · Quality of life (healthcare (4 works) · Cognition (3 works) · Health Systems, Economic Evaluations, Quality of Life (3 works) · Nursing (3 works) · Psychometrics (3 works)